The global preclinical medical device testing services market is valued at USD 4.30 billion in 2026 and is projected to reach about USD 9.60 billion by 2035, growing at a 9.2% CAGR from 2026 to 2035 (2025 market size USD 3.96 billion). Growth is driven by rising R&D, the need to demonstrate safety and effectiveness for more complex devices, and strict regulations.
Market Snapshot
- Revenue, 2026: 4.30 Billion
- Forecast, 2035: 9.60 Billion
- CAGR, 2026-2035: 9.2%
- Report Coverage: Global
Key Companies
- SGS SA
- Eurofins Scientific
- Pace Analytical Services LLC
- Intertek Group Plc
- WUXI APPTEC
- TÜV SÜD AG
- Sterigenics International LLC
- Nelson Labs
- North American Science Associates Inc.
- Charles River Laboratories International Inc.
About Healthcare Foresights
Healthcare Foresights provides market research and consulting across the healthcare and life sciences industry, combining industry research, analytical expertise and technology-enabled solutions to help companies, investors and decision-makers identify opportunities and drive growth. For the full report, customization or a sample, contact our team.
